Malignant fibrous histiocytoma (MFH) is a type of cancer that typically occurs in soft tissues, such as the muscles and tendons. When it starts in the bones, doctors call it MFH of the bone. The up-to ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

Adding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the extremity, a randomized trial showed. In patients with mostly undifferentiated ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A 56-year-old man presented to the ED with 3 months of ...

Please provide your email address to receive an email when new articles are posted on . A phase 2 trial conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated the ...

(RTTNews) - Intensity Therapeutics, Inc. (INTS), a late-stage clinical biotechnology company focused on immune-based cancer therapies, announced Tuesday that its INVINCIBLE-3 Study has been authorized ...